ABSTRACT
INTRODUCTION
Genome-wide association studies have become a powerful approach for uncovering the genetic variants that impact human phenotypes. Simulation studies are a popular and inexpensive approach to evaluate new methods for statistical analysis (Su et al., 2009) and to examine the power of different experimental designs (Spencer et al., 2009) .
The traditional approach of simulating a population forwards (Lambert, 2008) or backwards (Hudson, 2002) in time ignore the large amount of observed genetic data that are available, can be computationally intensive and can struggle to match real LD patterns. To overcome these problems, Spencer et al. (2009) introduced a novel simulation approach, HAPGEN, which uses an alternative resampling approach. Given a reference panel of haplotypes, this method produces a sample of haplotypes with patterns of LD similar to those in the reference panel. Using the HapMap3 and 1000G haplotype data as reference panels, HAPGEN is able to simulate data for many populations. In addition, it is fast and can simulate a single disease SNP under a general disease model, allowing the user to specify the risk allele and heterozygote and * To whom correspondence should be addressed. † The authors wish it to be known that, in their opinion, the last two authors should be regarded as joint Last Authors. homozygote relative risks. Other resampling methods also exist (Li and Li, 2008; Wright et al., 2007) , but they and HAPGEN can only simulate a single disease SNP on the same haplotype. There are many complex diseases with multiple-associated loci on the same chromosome, some of them in close proximity (e.g. Strange et al., 2010) , so the ability to simulate multiple disease SNPs on the same chromosome would be desirable. To address this issue, we have devised a new approach, extending HAPGEN, to simulate multiple nearby disease SNPs on the same chromosome.
METHODS
The HAPGEN2 simulation approach is similar to that of HAPGEN and is based on the Li and Stephens (LS) model (Li and Stephens, 2003) of LD. Briefly, given a reference panel of haplotypes,
and h (i,j) ∈{0,1}, the LS model models each newly simulated haplotype as an imperfect mosiac of the haplotypes in H R and the haplotypes that have already been simulated (see below for more details). Simulation of casecontrol data is based on a set of disease SNPs, D ={d k : d k ∈{1,...,L},k = 1,...,K} with effect sizes and RR ={(rr 1 k ,rr 2 k )}, where rr 1 k and rr 2 k are the disease risks of carrying one and two copies of the 1 allele relative to carrying two copies of the 0 allele at d k , which combine multiplicatively across the K disease SNPs. The haplotypes, H P ={h r+1 ,...,h p }, for the control individuals are simulated first, followed by the haplotypes, H Q ={h p+1 ,...,h q }, for the case individuals.
Simulating control data
We simulate the control data as population controls (so that some of them may be cases) and simulate each additional haplotype, h i+1 ∈ H P , sequentially under the LS model. We use the copying states, z (i+1,j) ∈{1,...,i}, which evolve in a Markov manner, to indicate the haplotype that h (i+1,j) copies at site j. We simulate each haplotype in three stages. First, the cross-over events, which are locations where z (i+1,j) = z (i+1,j−1) , are simulated according to the transition probabilities
where I z is 1 if z = z (i+1,j−1) and 0 otherwise, and ρ j is genetic distance between SNPs (j −1) and j. Conceptually, the cross-over events mimicks the effect of recombination and breaks up h i+1 into independent segments, {h (i+1,s 1 ) ,...,h (i+1,sn) }, where each segment is a haplotype of SNPs between two cross-over events. Second, the copying state for each segment is sampled uniformly from {1,...,i}. Finally, the allele at each SNP is simulated conditional on the copying state and a mutation parameter µ i : 
Simulating case data
We simulate the case haplotypes in a similar way, but we simulate them sequentially in pairs (with each pair corresponding to a case individual) and oversample haplotypes carrying the risk alleles based on the relative risks. Simulation of each haplotype pair, (h i+1 ,h i+2 ) ∈ H Q , proceeds in four stages. First, the cross-over events are simulated in the same way as for the controls, according to (1). Second, the alleles at the disease SNPs are simulated. Let (h 1 D ,h 2 D ) be the subset of (h i+1 ,h i+2 ) that consist of the alleles at the disease SNPs, so that h j D = (h (i+j,d 1 
where
is the genotype at d k , and p(h s ) is the frequency of the haplotype segment h s in H R and H P . Third, the copying state for each segment, h (i+1,s) , is simulated independently and is drawn uniformly from {1,...,i}, like we do for the controls, if s does not include any disease SNPs; or else it is drawn from
and 0 otherwise. Finally, each allele for h (i+1,s) is simulated according to (2). Copying states and alleles for h i+2 are simulated in the same way.
RESULTS
To demonstrate HAPGEN2, we have simulated, using HapMap2 (Barrett et al., 2005) , shows the similarity between the LD patterns of the reference panel (top) and the simulated haplotypes (bottom). The top plot in Figure 2 shows the −log 10 (P-values), for the log-additive test, across the region, illustrating the signal of association at the disease SNPs; subsequent plots show the P-values conditioned on the genotypes at d 1 , at d 1 and d 2 and at d 1 , d 2 and d 3 , respectively, confirming that there are indeed three independent disease SNPs.
DISCUSSION
We have introduced a new resampling method that can simulate multiple disease SNPs on the same haplotype, which will be particularly useful for investigating disease models involving multiple disease SNPs within close proximity. HAPGEN2 is fast, simple to use and available as a C++ package from http://www.stats.ox.ac.uk/~marchini/software/gwas/gwas.html, along with instructions and supporting resources, such as recombination rates, HapMap and 1000G reference panels. 
